Literature DB >> 640779

Ocular absorption and metabolism of topically applied epinephrine and a dipivalyl ester of epinephrine.

C P Wei, J A Anderson, I Leopold.   

Abstract

An analogue of epinephrine (EPI), dipivalyl epinephrine (DPE), has been found to reduce intraocular pressure (IOP) significantly at lower concentrations than EPI itself. In order to understand the reason for this increased activity, the ocular penetration, distribution, and metabolism of these two compounds were compared. About 10 times as much DPE as EPI was absorbed by rabbit eyes, with the cornea as the major repository for the increased amount of drug absorbed. Comparison of the partition coefficients of the two compounds showed DPE to be from 100 to 600 times as lipophilic as EPI. The radioactive materials found in the aqueous humor after treatment with either compound had the same mobility in a thin-layer chromatographic system. The data indicate that following the increased penetration of the lipophilic prodrug, DPE is hydrolyzed to EPI in the eye.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 640779

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  10 in total

Review 1.  Prodrug strategies in ocular drug delivery.

Authors:  Megha Barot; Mahuya Bagui; Mitan R Gokulgandhi; Ashim K Mitra
Journal:  Med Chem       Date:  2012-07       Impact factor: 2.745

2.  Epinephrine effects on major cell types of the aqueous outflow pathway: in vitro studies/clinical implications.

Authors:  J A Alvarado; L Franse-Carman; G McHolm; C Murphy
Journal:  Trans Am Ophthalmol Soc       Date:  1990

Review 3.  Ocular drug delivery. Pharmacokinetic considerations.

Authors:  R D Schoenwald
Journal:  Clin Pharmacokinet       Date:  1990-04       Impact factor: 6.447

Review 4.  Targeted Ocular Drug Delivery with Pharmacokinetic/Pharmacodynamic Considerations.

Authors:  Jie Shen; Guang Wei Lu; Patrick Hughes
Journal:  Pharm Res       Date:  2018-09-25       Impact factor: 4.200

Review 5.  Clinical pharmacokinetics of various topical ophthalmic delivery systems.

Authors:  J P Frangie
Journal:  Clin Pharmacokinet       Date:  1995-08       Impact factor: 6.447

Review 6.  Recent advances in ophthalmic drug delivery.

Authors:  Uday B Kompella; Rajendra S Kadam; Vincent H L Lee
Journal:  Ther Deliv       Date:  2010-09

7.  Epinephrine distribution after topical administration to phakic and aphakic eyes.

Authors:  S G Kramer
Journal:  Trans Am Ophthalmol Soc       Date:  1980

8.  A single-blind randomised trial comparing adrenaline 1.0% with dipivalyl epinephrine (propine) 0.1% in the treatment of open-angle glaucoma and ocular hypertension.

Authors:  K B Mills; N A Jacobs
Journal:  Br J Ophthalmol       Date:  1988-06       Impact factor: 4.638

9.  A new strategy to sustained release of ocular drugs by one-step drug-loaded microcapsule manufacturing in hydrogel punctal plugs.

Authors:  Jiajun Xie; Changjun Wang; Qingyao Ning; Qi Gao; Changyou Gao; Zhongru Gou; Juan Ye
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-09-08       Impact factor: 3.117

10.  Cardiovascular effects of epinephrine and dipivalyl epinephrine applied topically to the eye in patients with glaucoma.

Authors:  C R Kerr; I Hass; S M Drance; M B Walters; M Schulzer
Journal:  Br J Ophthalmol       Date:  1982-02       Impact factor: 4.638

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.